Skip navigation
Agenda

Elevate Best Practices in Fair Market Value Calculations to Ensure Compliance

May 3-4, 2018
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE THURSDAY, MAY 3, 2018

7:45

Registration and Continental Breakfast

8:45

Co-Chairs’ Welcome and Opening Remarks

Richard Eschle
Executive Director, Corporate Ethics & Compliance
Eisai Inc.

Mark DeWyngaert
Managing Director, Life Sciences
Deloitte & Touche LLP

Key Considerations for FMV Frameworks

9:00

Harmonize FMV Programs and Processes Internally to Enhance Operations

Valerie Burkholder
Consultant, FMV and Physician Payment Reporting
Eli Lilly and Company (Retired)

9:45

Develop Effective Systems for Processing Exceptions

Kyla Garrison
Global Health Care Provider Interactions
W.L. Gore & Associates, Inc.

10:30

Networking and Refreshment Break

11:00

Understand Challenges in the Application of Bona Fide Service Fee Test and its Operational Implications

John Moose
Principal
Polaris, a QuintilesIMS Company

Samantha Sutherland
Engagement Manager
Polaris, a QuintilesIMS Company

11:45

Key Considerations of Managing a Fee-for-Service and Fair Market Value Framework

Sajid Saeed
Fair Market Value and Fee for Service Lead
GSK

12:30

Networking Luncheon

1:30

PANEL DISCUSSION Analyze Challenges in Utilizing FMV Calculations in Rare Disease and Specialty Areas

MODERATOR:

Landan Ansell
Director, Forensic Services
PwC

PANELISTS:

Meghan Bagshaw
Director Global Medical Affairs Operations
SAGE Therapeutics

Richard Eschle
Executive Director, Corporate Ethics & Compliance
Eisai Inc.

2:15

Modernize Your FMV and BFSF Program —
How Advanced Technology, Tools and Processes Can Help

Rick Moore
Senior Manager
Deloitte & Touche LLP

Nick Lynch
Manager
Deloitte & Touche LLP

3:00

Networking and Refreshment Break

Explore Applications of FMV in Clinical Trials
and Enhance HCP Interactions

3:30

Analyze the Application of FMV in Clinical Trials

Masha Chestukhin
Associate Director, Compliance Officer R&D & IA and FMV
Sanofi-Genzyme

Kyle Faget
Special Counsel
Foley & Lardner LLP

4:15

Enhance HCP Relationship Management Through Compliant Interactions

Heather Reavey
Senior Manager, HCP Consulting Management
Olympus Corporation of the Americas

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO FRIDAY, MAY 4, 2018

8:00

Continental Breakfast

8:30

Co-Chairs’ Review of Day One

Richard Eschle
Executive Director, Corporate Ethics & Compliance
Eisai Inc.

Mark DeWyngaert
Managing Director, Life Sciences
Deloitte & Touche LLP

Implement and Maintain
Effective Global FMV Practices

8:45

Build Effective Strategies and Methods for Global FMV Implementation

Davida Baker
Director, Transparency Reporting
AstraZeneca

Kyla Garrison
Global Health Care Provider Interactions
W.L. Gore & Associates, Inc.

Laura Skinner
Senior Manager, Life Sciences Advisory
Deloitte & Touche LLP

9:30

Review Cross-Border Complexities in HCP Engagements

Julie DeLong, CFA
Managing Director, Transaction Advisory Services
Navigant

Melanie Fagan
Lead, External Expert Engagement HUB
GSK

Jim Heintzelman
Director, Compliance, Hospital Business
Mallinckrodt Pharmaceuticals

10:15

Networking and Refreshment Break

Elevate Transparency and Compliance Through Strong Systems and Documentation

10:45

Explore Best Practices for Reporting of HCP Spend

Margaret Rossini
Associate Director, Compliance Government Reporting
Sandoz Inc.

11:30

Assess FMV Compliance Monitoring and Risk Management Strategies

Richard Eschle
Executive Director, Corporate Ethics & Compliance
Eisai Inc.

12:15

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE THURSDAY, MAY 3, 2018

7:45

Registration and Continental Breakfast

8:45

Co-Chairs’ Welcome and Opening Remarks

Richard Eschle
Executive Director, Corporate Ethics & Compliance
Eisai Inc.

Mark DeWyngaert
Managing Director, Life Sciences
Deloitte & Touche LLP

Key Considerations for FMV Frameworks

9:00

Harmonize FMV Programs and Processes Internally to Enhance Operations

Valerie Burkholder
Consultant, FMV and Physician Payment Reporting
Eli Lilly and Company (Retired)

9:45

Develop Effective Systems for Processing Exceptions

Kyla Garrison
Global Health Care Provider Interactions
W.L. Gore & Associates, Inc.

10:30

Networking and Refreshment Break

11:00

Understand Challenges in the Application of Bona Fide Service Fee Test and its Operational Implications

John Moose
Principal
Polaris, a QuintilesIMS Company

Samantha Sutherland
Engagement Manager
Polaris, a QuintilesIMS Company

11:45

Key Considerations of Managing a Fee-for-Service and Fair Market Value Framework

Sajid Saeed
Fair Market Value and Fee for Service Lead
GSK

12:30

Networking Luncheon

1:30

PANEL DISCUSSION Analyze Challenges in Utilizing FMV Calculations in Rare Disease and Specialty Areas

MODERATOR:

Landan Ansell
Director, Forensic Services
PwC

PANELISTS:

Meghan Bagshaw
Director Global Medical Affairs Operations
SAGE Therapeutics

Richard Eschle
Executive Director, Corporate Ethics & Compliance
Eisai Inc.

2:15

Modernize Your FMV and BFSF Program —
How Advanced Technology, Tools and Processes Can Help

Rick Moore
Senior Manager
Deloitte & Touche LLP

Nick Lynch
Manager
Deloitte & Touche LLP

3:00

Networking and Refreshment Break

Explore Applications of FMV in Clinical Trials
and Enhance HCP Interactions

3:30

Analyze the Application of FMV in Clinical Trials

Masha Chestukhin
Associate Director, Compliance Officer R&D & IA and FMV
Sanofi-Genzyme

Kyle Faget
Special Counsel
Foley & Lardner LLP

4:15

Enhance HCP Relationship Management Through Compliant Interactions

Heather Reavey
Senior Manager, HCP Consulting Management
Olympus Corporation of the Americas

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO FRIDAY, MAY 4, 2018

8:00

Continental Breakfast

8:30

Co-Chairs’ Review of Day One

Richard Eschle
Executive Director, Corporate Ethics & Compliance
Eisai Inc.

Mark DeWyngaert
Managing Director, Life Sciences
Deloitte & Touche LLP

Implement and Maintain
Effective Global FMV Practices

8:45

Build Effective Strategies and Methods for Global FMV Implementation

Davida Baker
Director, Transparency Reporting
AstraZeneca

Kyla Garrison
Global Health Care Provider Interactions
W.L. Gore & Associates, Inc.

Laura Skinner
Senior Manager, Life Sciences Advisory
Deloitte & Touche LLP

9:30

Review Cross-Border Complexities in HCP Engagements

Julie DeLong, CFA
Managing Director, Transaction Advisory Services
Navigant

Melanie Fagan
Lead, External Expert Engagement HUB
GSK

Jim Heintzelman
Director, Compliance, Hospital Business
Mallinckrodt Pharmaceuticals

10:15

Networking and Refreshment Break

Elevate Transparency and Compliance Through Strong Systems and Documentation

10:45

Explore Best Practices for Reporting of HCP Spend

Margaret Rossini
Associate Director, Compliance Government Reporting
Sandoz Inc.

11:30

Assess FMV Compliance Monitoring and Risk Management Strategies

Richard Eschle
Executive Director, Corporate Ethics & Compliance
Eisai Inc.

12:15

Close of Conference